Related Experiment Videos
The uganda study on HPV variants and genital cancers
F M Buonaguro1, M L Tornesello, I Salatiello
1Division of Viral Oncology and AIDS Reference Center, Ist. Naz. Tumori 'Fond. G. Pascale', Napoli, Italy.
Summary
Human papillomavirus (HPV) type 16 Af1 is prevalent in Ugandan genital cancers. This suggests HPV-16 Af1 plays a key role in cancer development and informs a Ugandan HPV vaccine program.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Genital cancers are the most frequent diagnosis in Ugandan men and women since the 1950s.
- Genetic studies identified HPV-16 variants, including the Af1 class and a new Af1-u subclass.
Purpose of the Study:
- Analyze HPV strain and variant prevalence in Ugandan anogenital lesions.
- Determine the role of HPV in lesion pathogenesis.
- Inform the development of a Ugandan preventive HPV vaccine program.
Main Methods:
- Collected 200 scrapes/biopsies from male and female subjects with genital lesions.
- Utilized PCR amplification of L1 conserved region and E6/E7 genes.
- Performed nucleotide sequence, homology, and phylogenetic analyses.
Main Results:
- HPV-16 Af1 sequences identified in 100% of penile cancer tissues.
- HPV-16 Af1 detected in 6.25% of ectocervical scrapes.
- Narrowing HPV patterns in advanced lesions suggest HPV-16 Af1 progression to cancer.
Conclusions:
- HPV-16 Af1 is strongly associated with genital cancer progression in Uganda.
- Findings support targeted HPV vaccine development for Uganda.